Treatment of burns in children.
Decreases in mortality from major thermal injury over the last 20 years have been due to advances in resuscitation, control of infection, support of the hypermetabolic response, and early closure of the burn wound. Of these advances in burn care, early wound closure has progressed the most in the last five years. The restoration of the protective functions of the skin is of primary importance to the recovery of the burn patient. Biologic dressings (pigskin, amnion, human skin allograft) when applied to fully debrided, relatively uncontaminated wounds have been shown to adhere to the wound surface, reduce the wound colony counts, limit fluid and protein loss, reduce pain, and increase the rate of epithelialization over that obtained with application of topical antimicrobial agents.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage; D001424:Bacterial Infections / Q000517:prevention & control; D001684:Biological Dressings; D001803:Blood Transfusion; D001831:Body Temperature; D002056:Burns / Q000378:metabolism / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D002059:Burns, Inhalation / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D004630:Emergencies; D004734:Energy Metabolism; D005260:Female; D005440:Fluid Therapy / Q000379:methods; D006801:Humans; D007223:Infant; D008297:Male; D012138:Respiratory Therapy; D012709:Serum Albumin / Q000008:administration & dosage
D000890:Anti-Infective Agents; D012709:Serum Albumin